SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

PICCIN, Daniela
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.911
EU - Europa 454
AS - Asia 327
OC - Oceania 1
Totale 2.693
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.904
CN - Cina 201
DE - Germania 139
UA - Ucraina 119
SG - Singapore 68
GB - Regno Unito 61
TR - Turchia 52
IT - Italia 30
SE - Svezia 30
FI - Finlandia 28
RU - Federazione Russa 19
BE - Belgio 11
FR - Francia 9
CA - Canada 7
NL - Olanda 3
CZ - Repubblica Ceca 2
IE - Irlanda 2
IN - India 2
IR - Iran 2
AU - Australia 1
BD - Bangladesh 1
KZ - Kazakistan 1
RO - Romania 1
Totale 2.693
Salva come PNG Salva come JPEG
Città #
Ashburn 346
Woodbridge 277
Fairfield 164
Jacksonville 139
Chandler 131
Houston 129
Ann Arbor 99
Seattle 69
Wilmington 60
Santa Clara 59
Beijing 54
Cambridge 54
Singapore 51
Addison 47
Izmir 44
Nanjing 38
Princeton 27
Milan 23
Boardman 21
San Diego 21
Shanghai 17
Dearborn 16
Shenyang 15
Brussels 11
Kunming 11
Guangzhou 8
Hebei 8
Jiaxing 8
Nanchang 8
New York 8
Jinan 7
Changsha 6
Los Angeles 6
Norwalk 6
San Mateo 6
Leawood 5
Mountain View 5
Redwood City 5
Des Moines 4
Falls Church 4
Tappahannock 4
Tianjin 4
Washington 4
Hangzhou 3
Monmouth Junction 3
Montréal 3
Munich 3
Ardabil 2
Augusta 2
Dublin 2
Hefei 2
Helsinki 2
London 2
Ottawa 2
Prescot 2
Taizhou 2
Toronto 2
Verona 2
Acton 1
Almaty 1
Bremen 1
Brno 1
Changchun 1
Delhi 1
Dhaka 1
Ferrara 1
Formia 1
Jinhua 1
Kilburn 1
Lappeenranta 1
Mcallen 1
Messina 1
Mumbai 1
Ningbo 1
Paris 1
Philadelphia 1
Wuxi 1
Yellow Springs 1
Zhengzhou 1
Totale 2.084
Salva come PNG Salva come JPEG
Nome #
SRC homology-2-containing protein tyrosine phosphatase-1 restrains cell proliferation in human medullary thyroid carcinoma 340
Cyclooxygenase-2 inhibitors reverse chemoresistance phenotype in medullary thyroid carcinoma by a permeability glycoprotein-mediated mechanism 148
Cyclooxygenase-2 inhibitors prevent the development of chemoresistance phenotype in a breast cancer cell line by inhibiting glycoprotein p-170 expression. 144
Selective activation of somatostatin receptor subtypes differentially modulates secretion and viability in human medullary thyroid carcinoma primary cultures: potential clinical perspectives. 143
Pasireotide, a multiple somatostatin receptor subtypes ligand, reduces cell viability in non functioning pituitary adenomas by inhibiting Vascular Endothelial Growth Factor secretion. 139
Proteasomes and RARS modulate AIMP1/EMAP II secretion in human cancer cell lines. 122
Somatostatin receptor subtype 1 selective activation reduces cell growth and calcitonin secretion in a human medullary thyroid carcinoma cell line. 113
miR-15a and miR-16-1 down-regulation in pituitary adenomas 112
An in vivo OctreoScan-negative adrenal pheochromocytoma expresses somatostatin receptors and responds to somatostatin analogs treatment in vitro 109
Identification of differentially expressed microRNAs by microarray: a possible role for microRNA genes in pituitary adenomas. 107
null 106
Somatostatin, but not somatostatin receptor subtypes 2 and 5 selective agonists, inhibits calcitonin secretion and gene expression in the human medullary thyroid carcinoma cell line, TT. 105
Antiproliferative effects of somatostatin analogs in pituitary adenomas 94
Role of complex Cdk4/Cyclin D1 in somatostatin subtype 2 receptor-mediated inhibition of cell proliferation of a medullary thyroid carcinoma cell line in vitro 91
SHP-1 restrains cell proliferation in human medullary thyroid carcinoma 88
Somatostatin receptor subtype 1 selective activation in human growth hormone- and prolactin-secreting pituitary adenomas: effects on cell viability, growth hormone and prolactin secretion. 87
Multiple somatostatin receptor subtypes activation reduces cell viability in non-functioning pituitary adenomas by inhibiting Vascular Endothelial Growth Factor secretion 85
Chemoresistance of Medullary thryroid carcinoma cells is reversed by COX-2 inhibitors in vitro through a PGE2-dependent mechanism 73
Evidence for differential effects of selective somatostatin receptor subtype agonists on alpha-subunit and chromogranin A secretion and on cell viability in human non-functioning pituitary adenomas in vitro 73
Selective Cyclo-oxygenase 2 inhibitors revert chemoresistance In Medullary thyroid carcinoma by a mechanism mediated by P-gp and PGH2 72
Role of complex cyclin D1/Cdk4 in somatostatin subtype 2 receptor-mediated inhibition of cell proliferation of a medullary thyroid carcinoma cell line in vitro 71
Somatostatin inhibits a medullary thyroid carcinoma cell line growth by activating SHP-1 69
Somatostatin analogs in vitro effects in a growth hormone-releasing hormone (GHRH)-secreting bronchial carcinoid 68
Somatostatin differentially influences proliferation and gene expression by modulating SHP-1 and cAMP pathways in a human medullary thyroid carcinoma cell line 61
SSTR subtypes expression pattern influences the antiproliferative effects of somatostatin and lanreotide on human medullary thyroid carinomas in vitro 60
Dopamine receptor subtype 2 and somatostatin receptor subtype 5 expression influences somatostatin analogs effects on human somatotroph pituitary adenomas in vitro 26
Totale 2.706
Salva come PNG Salva come JPEG
Categoria #
all - tutte 11.547
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 11.547
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020337 0 0 0 0 42 61 43 54 37 54 39 7
2020/2021287 34 29 8 33 12 29 11 32 6 34 49 10
2021/2022330 10 41 31 6 18 12 17 11 10 21 33 120
2022/2023281 28 24 24 35 36 46 24 16 31 1 12 4
2023/2024405 16 28 3 5 12 26 6 273 4 1 0 31
2024/2025142 12 10 44 12 64 0 0 0 0 0 0 0
Totale 2.706